Patient-level meta-analysis of randomized trials of aromatase inhibitors (AI) versus tamoxifen (Tam).
John F. Forbes
Honoraria - AstraZeneca; Novartis
Mitchell Dowsett
Research Funding - AstraZeneca; Pfizer
Rosie Bradley
No relevant relationships to disclose
James N. Ingle
No relevant relationships to disclose
Tomohiko Aihara
No relevant relationships to disclose
Judith M. Bliss
Honoraria - Pfizer
Research Funding - Pfizer
Francesco Mario Boccardo
Honoraria - AstraZeneca
Research Funding - AstraZeneca
Alan S. Coates
No relevant relationships to disclose
R. Charles Coombes
No relevant relationships to disclose
Jack M. Cuzick
Honoraria - AstraZeneca
Research Funding - AstraZeneca
Peter Christian Dubsky
Honoraria - AstraZeneca; Novartis; Pfizer
Michael Gnant
No relevant relationships to disclose
Manfred Kaufmann
No relevant relationships to disclose
Lucy S Kilburn
No relevant relationships to disclose
Francesco Perrone
Honoraria - Novartis; Pfizer
Daniel Rea
Consultant or Advisory Role - AstraZeneca; Novartis; Pfizer
Honoraria - Novartis; Pfizer
Research Funding - Pfizer
Beat J. K. Thurlimann
Stock Ownership - Novartis
Cornelis J. H. Van De Velde
No relevant relationships to disclose
Christina Davies
No relevant relationships to disclose
Richard G. Gray
No relevant relationships to disclose